{"id":934353,"date":"2026-02-04T17:20:08","date_gmt":"2026-02-04T22:20:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/"},"modified":"2026-02-04T17:20:08","modified_gmt":"2026-02-04T22:20:08","slug":"quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/","title":{"rendered":"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CINCINNATI, Feb.  04, 2026  (GLOBE NEWSWIRE) &#8212; Quipt Home Medical Corp. (\u201c<strong>Quipt<\/strong>\u201d or the \u201c<strong>Company<\/strong>\u201d) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the \u201c<strong>Circular<\/strong>\u201d) in connection with Quipt\u2019s upcoming special meeting (the \u201c<strong>Meeting<\/strong>\u201d) of the holders (the \u201c<strong>Shareholders<\/strong>\u201d) of Quipt\u2019s common shares (the \u201c<strong>Shares<\/strong>\u201d) to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt\u2019s profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the \u201c<strong>SEC<\/strong>\u201d) on the EDGAR website at www.sec.gov, and on Quipt\u2019s website at https:\/\/quipthomemedical.com\/sec-filings\/. Mailing to Shareholders of the Circular and related materials for the Meeting (collectively, the \u201c<strong>Meeting Materials<\/strong>\u201d) has also commenced and Shareholders should receive the Meeting Materials shortly. The Meeting is being held for Shareholders to consider and vote on a special resolution (the \u201c<strong>Arrangement Resolution<\/strong>\u201d) approving a plan of arrangement (the \u201c<strong>Arrangement<\/strong>\u201d) pursuant to which affiliates of Kingswood Capital Management, L.P. (\u201c<strong>Kingswood<\/strong>\u201d) and Forager Capital Management, LLC, will acquire all of the issued and outstanding Shares for cash consideration of US$3.65 per Share, representing a 54% premium to Quipt\u2019s 30-day VWAP as of December 12, 2025, the last trading day prior to the announcement of the Arrangement, all as more fully described in the Circular.<\/p>\n<p align=\"justify\">The Arrangement Resolution requires approval of: (i) at least 66\u2154% of the votes cast by Shareholders, present in person or represented by proxy at the Meeting; and (ii) in accordance with Multilateral Instrument 61-101 &#8211; <em>Protection of Minority Security Holders in Special Transactions<\/em> (\u201c<strong>MI 61-101<\/strong>\u201d), a simple majority of votes cast by the Shareholders, present in person or represented by proxy and entitled to vote at the Meeting, excluding the votes in respect of Shares cast by any \u201cinterested party\u201d, any \u201crelated party\u201d of an \u201cinterested party\u201d or any \u201cjoint actor\u201d (as such terms are defined in MI 61-101).<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Special Meeting on March 3, 2026<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The Company will hold the Meeting in person on March 3, 2026, at 10:00 a.m. (Eastern Standard Time) at the Hampton Inn &amp; Suites \u2013 Sarasota Bradenton Airport, 975 University Pkwy., Sarasota, Florida. Only Shareholders of record as of the close of business on January 22, 2026 are entitled to receive notice of and to vote at the Meeting.<\/p>\n<p>Shareholders are encouraged to read the Circular in its entirety and vote their Shares as soon as possible ahead of the proxy voting deadline of 10:00 a.m. (Eastern Standard Time) on February 27, 2026.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>How to Vote<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Even if you have never voted before, every vote will count no matter how many Shares you own. All Shareholders are encouraged to vote in advance of the Meeting by proxy, whether or not a Shareholder is intending to attend the Meeting in person. Details on how to vote can be found in the Circular.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Shareholder Questions and Assistance<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">Quipt has retained Carson Proxy Advisors as its strategic shareholder advisor and proxy solicitation agent in connection with the Arrangement. Shareholders who have questions about the Arrangement or require assistance with voting their Shares should contact Carson Proxy by telephone at 1-800-530-5189 (toll-free in North America) or 416-751-2066 (for calls outside North America), or by email at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UmqbQrUlIvk9oWcMdbjoWsg99YbAeagcramli_fsiNGFzBZmuFoN3Hhk_Seq1Gw1GhGBfchtpx_CguBELO4dX_BkMnstFUF_D-Lhquczh0Q=\" rel=\"nofollow\" target=\"_blank\">info@carsonproxy.com<\/a>, or contact Quipt in writing at its principal executive offices at 1019 Town Drive, Wilder, Kentucky 41076, Attention: Corporate Secretary, or by email to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vx_yvzEVrykGrgsbDhobXABfsMnPoAEGncIAH8Ctn9q7vEbebbTW7ZJiasrUTgaJGdZ4FGj4p72CroVm90zlu5GSsqVEjtvlyXQ_0if3-OLLqtJSyJ8fJVPsIrPMLaFi\" rel=\"nofollow\" target=\"_blank\">investorinfo@myquipt.com<\/a>.<\/p>\n<p>\n        <strong><br \/>\n          <u>Board Recommendation and Key Shareholder Support<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The board of directors of Quipt (the \u201c<strong>Board<\/strong>\u201d), after receiving outside legal and financial advice, unanimously recommends that Shareholders vote <strong><u>FOR<\/u><\/strong> the Arrangement Resolution.<\/p>\n<p align=\"justify\">Directors and executive officers of the Quipt who collectively hold approximately 11.3% of all issued and outstanding Shares, have entered into customary support and voting agreements (\u201c<strong>Voting Support Agreements<\/strong>\u201d) with the Purchaser (as defined below) pursuant to which they have agreed to vote all their Shares at the Meeting in favor of the Arrangement Resolution, subject to certain conditions. Additionally, Forager Fund, LP has also entered into a Voting Support Agreement with the Purchaser pursuant to which it has agreed, among other things, to vote its Shares, which represent approximately 9.5% of all issued and outstanding Shares, in favor of the Arrangement Resolution.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <u>Receipt of Interim Order<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">The Company is also pleased to announce that the Supreme Court of British Columbia (the \u201c<strong>Court<\/strong>\u201d) issued an interim order dated January 23, 2026 in connection with the Arrangement, which, among other things, authorizes the calling and holding of the Meeting to consider and vote on the Arrangement, and sets out procedures for the conduct of the Meeting.<\/p>\n<p align=\"justify\">In addition to satisfying the conditions set forth in the Arrangement Agreement (as defined below) and described in the Circular, the implementation of the Arrangement is subject to obtaining the final order of the Court, approval of the Arrangement from Shareholders at the Meeting and satisfaction of certain other conditions to implementing the Arrangement, as set forth in the arrangement agreement (the \u201c<strong>Arrangement Agreement<\/strong>\u201d) dated December 14, 2025 among Quipt, 1567208 B.C. Ltd. (the \u201c<strong>Purchaser<\/strong>\u201d) and REM Aggregator, LLC, a copy of which is available on Quipt\u2019s \u200eprofile on SEDAR+ at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L3neIGQKMHpjg6MBqpi2_0ILaG9rAeFy6Ck-r_I3E83JbVMXMx0zmIDbvXAn3dUiSDFEyqy8S1ySCOZAb6XR70yhdQaCMhbsZAF-PkJuFGjDfj1ENXk-_10gfI9xnD_0ywVSJN5PQslQdvtwKeW2MeGMjOfPEye7PYIbhQtuDqSzsbLh5u5D5yZi1atmUtXWj8uK5KKBW0yqc6-e06WTRAdUepT1uAA9k8rOEJinJ-uf_VAel6YLYNgX-jjik3g7FRfl0COA5Jn0upKEhZ3kMvl0-pgmMaaE4v8BnmD_YZ_vAvMNpW3L808LYFIqbENGPzIL7WP7yVERBTv1pq8QRO7V3h40IKWJE9QF7J_8rp8-6Vvkdl8U9Wn28rLA5aa5ntWaDFcWiiOFFdN5D2E8xSRL1TjXZ4IpgFPw2yQh_WQ=\" rel=\"nofollow\" target=\"_blank\">www.sedarplus.com<\/a> and has been filed with the SEC on the EDGAR website at \u200e<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L3neIGQKMHpjg6MBqpi2_8yZZ3K9TDBugNyjDROkoyR750MfQvyeebnm9OIuCh7-QpSBhqfCk8jibt8UiidGXKs_4YW7Co694QK30ec_JibhI7AiOPjbPAiROhX4PHrLGBp-KAjok07VLGhVhODNRTAor9g3LVumUl3vBEFOAks5-k1shn2XZ2sIvIsysX33455r8uOhJvpQOVC1P1sL2srmcnu1_EJUMGhXwqizpgQ1jObE8cmsWd0pg1y0rLUDThR5_CDDrS0FrwfeTktAOuk46HGJiqaHp61_0XFzcuSsuYMI5JxlRt-HMlHTOqwpbAnX7gZLNhF9W1G_ysh4xJXb2cjP_gOozuCUTDQUWRsspP6BeONzgbDsqxHtRf3_IXm6uY5jeRrqeYKpyAAHjA==\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a>\u200e.\u200e<\/p>\n<p>\n        <strong><br \/>\n          <u>Additional Details<\/u><br \/>\n        <\/strong>\n      <\/p>\n<p align=\"justify\">For a more detailed description of the Arrangement and the Arrangement Resolution to be voted upon at the Meeting, Shareholders are urged to review and carefully consider the Circular and Meeting Materials, as they contain important information concerning the Arrangement and the rights and entitlements of the Shareholders in relation thereto and consult with their financial, tax, legal and other professional advisors.<\/p>\n<p>\n        <strong>ABOUT QUIPT HOME MEDICAL<\/strong>\n      <\/p>\n<p align=\"justify\">The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company\u2019s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient\u2019s services, and making life easier for the patient.<\/p>\n<p align=\"justify\">\n        <strong>Additional Information about the Arrangement and Where to Find It<\/strong>\n      <\/p>\n<p align=\"justify\">This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote, consent or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. This communication has been prepared in respect of the Arrangement pursuant to the terms of the Arrangement Agreement and may be deemed to be soliciting material relating to the Arrangement. In connection with the Arrangement, Quipt has filed the Circular relating to the Meeting with the SEC and on SEDAR+ on February 4, 2026. Additionally, Quipt may file other relevant materials in connection with the Arrangement with the SEC and on SEDAR+. <strong>Securityholders of Quipt are urged to read the Circular and any other relevant materials that may be filed with the SEC and on SEDAR+, as well as any amendments or supplements to these documents, carefully in their entirety before making any voting or investment decision with respect to the Arrangement because they contain or will contain important information about the Arrangement and the parties to the Arrangement Agreement.<\/strong> The Circular was first mailed to Quipt&#8217;s shareholders on or about February 4, 2026. You can obtain a copy of the Circular, as well as other filings containing information about the Arrangement and the parties to the Arrangement Agreement made by Quipt, free of charge on EDGAR at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L3neIGQKMHpjg6MBqpi2_zCzEgwxSWaz-sJjNTJZDskpVjtBGRn17RNGNDReGuehX_q0xJfyTW_De4m-uj4q7YS2CcqzKeP8ATjQ0i23MXtGQZyB8X8q2IKNr8yWVaOuahdUeOvsmbzzMhYPs2d5xyvwO18ZlN2EcMljrw1xfT8zogFAN2OtrBUh2YZBKpOzjlWq8UizaMSHWmJleQLHFpX4eHDODWiZfockbZ9FTRnVJhEiMIIjSsPxt0bWBbrkOfQ9ay-FTB99QifmgM6GYRYWKvYX4r6lQ7LRYTdcLmhI2GuO1MtREN8VbLij9mSjn2Dm66rPWIEeXZT3fJSy0VFa11KdY72QBpoqu1ZSqIO4d18hkiBlTRdRwCXxKUGM\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a>, on SEDAR+ at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L3neIGQKMHpjg6MBqpi2_-wJasHNwY3kJRo5OVebFgUcGMxH_HRg8IBirzRAfq_i6S1xmSwoazJmQEvD7WAZEQ5ziZh-Qeckbb4EX2jhyvbsUb8Wzs-5fq5K4On1cQN3vBrjKw9w3SmS55Lz1tvcyAZF-aTY5v64uEtZI1DtIMtlWuB_7OIulcAX9s49fz_HuFH-l1CdogWGRHayri6Y5BPfm-0VWYcZ7_es8hirY4vBTZgsZsCtrAfuUZlLjUsEc5-_xGwR9MNLVgHGg8B_zt6D5suEsiCOWPp4qeSOZ8ij-A9m-6dwaPonnfKDlEyvEifs0Y5xoj3RvYnULqbHCceBuLPt9GhARBq6pUEwsrgFih59vM6AAZ-V1QnvEHEvKePINP5fwRAUweHVE7h97g==\" rel=\"nofollow\" target=\"_blank\">www.sedarplus.com<\/a>, or on Quipt&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YREq1Y4IJu9Eiq3cp2y2nZDlTeN6TPHKKkhKVgLKk5WJBkQynEdPFKvyiYfgtLZ4t8mkmbtqhAvzM6AnKE8fhZLKPZC7nsCWW4Cv9aNUSlDAS0X-aDImyJg4UIhXi1XWpUnBV6FLINRGxNi5JOOxg1CgIy0xavCSqlEAZXm4PLBTDT9UAU1xQHr9hDgafAO3MzgpG0PLJFZqPmZEKqDzma5cwMvcQQNYmb0G2biskWbLwLyF2w7UDYsfzvhyVCTPO14oIb3Bjj4_G5MkUn06B53kYnmPY3mE0olZ3DXw3qGHZjopEU2Sfdl4mB9ejhx6M9-p2HlUg8cYTZXzO4en_u036pr_IrBMn6Us56N2BFoD1mqm4BT8A7BBI6MAGfncslcJuQpgZMq_-gbotGhFVngBoA5WE0Nqb6a5mJvwFi8=\" rel=\"nofollow\" target=\"_blank\">https:\/\/quipthomemedical.com<\/a>. Information contained on, or that may be accessed through, the websites referenced in this communication is not incorporated into and does not constitute a part of this document. We have included these website addresses only as inactive textual references and do not intend them to be active links.<\/p>\n<p align=\"justify\">\n        <strong>Participants in the Solicitation<\/strong>\n      <\/p>\n<p>Quipt and its directors and executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of Quipt in respect of the Arrangement. Information about Quipt&#8217;s directors and executive officers is set forth in Quipt&#8217;s Form 10-K\/A, which was filed with the SEC on January 28, 2026 and is available on SEDAR+. Investors may obtain additional information regarding the interest of such participants by reading the Circular regarding the Arrangement.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">Certain statements contained in this press release constitute \u201cforward-looking statements\u201d within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or \u201cforward-looking information\u201d as such term is \u200e\u200e\u200e\u200e\u200e\u200edefined in applicable Canadian securities legislation (collectively, \u201cforward-looking statements\u201d). The words \u201cmay\u201d, \u201cwould\u201d, \u201ccould\u201d, \u201cshould\u201d, \u201cpotential\u201d, \u200e\u200e\u200e\u200e\u200e\u200e\u200e\u201dwill\u201d, \u201cseek\u201d, \u201cintend\u201d, \u201cplan\u201d, \u201canticipate\u201d, \u201cbelieve\u201d, \u201cestimate\u201d, \u201cexpect\u201d, \u201coutlook\u201d, or the negatives thereof or variations of such words, and similar expressions \u200e\u200e\u200e\u200e\u200eas \u200ethey relate to the Company are intended to \u200eidentify forward-looking statements, including: the proposed Arrangement and terms thereof; the anticipated timing of the Meeting; and the anticipated completion of the Arrangement, including receipt of Shareholder, Court and regulatory approval and satisfaction of closing conditions; and other statements that are not historical fact. All statements \u200eother \u200ethan \u200estatements of \u200e\u200ehistorical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-\u200elooking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Such statements reflect the \u200eCompany\u2019s \u200ecurrent \u200eviews and \u200e\u200eintentions with respect to future \u200eevents, and current information available to the \u200eCompany, and \u200eare \u200esubject to \u200e\u200ecertain risks, uncertainties and \u200eassumptions, including, without limitation: the ability to obtain required regulatory, Shareholder and Court approvals for the Arrangement, the timing of obtaining such approvals and the risk that such approvals may not be obtained in a timely manner or at all, and the risk that such approvals may be obtained on conditions that are not anticipated; the timing of closing of the Arrangement; the risk that the conditions to the Arrangement are not satisfied on a timely basis or at all and the failure of the Transaction to close for any other reason; the ability to achieve the expected benefits of the Arrangement. Many \u200efactors could cause the actual \u200eresults, \u200e\u200eperformance or achievements that may be \u200eexpressed \u200eor implied by such \u200eforward-looking statements to \u200evary from \u200e\u200ethose described herein should one or more \u200eof these \u200erisks or \u200euncertainties materialize. Examples of such \u200erisk \u200efactors \u200einclude, without limitation: risks related \u200eto credit, market \u200e\u200e\u200e(including equity, commodity, foreign exchange \u200eand interest \u200erate), \u200eliquidity, operational \u200e\u200e(including technology \u200eand \u200einfrastructure), reputational, insurance, \u200estrategic, \u200eregulatory, legal, \u200eenvironmental, and \u200ecapital adequacy; the \u200e\u200egeneral business and economic conditions in \u200ethe regions \u200ein which the \u200eCompany operates; \u200ethe ability of the \u200e\u200eCompany to execute on key priorities, including the \u200esuccessful \u200ecompletion of \u200eacquisitions, \u200ebusiness retention, and \u200e\u200estrategic plans and to attract, develop and retain \u200ekey \u200eexecutives; difficulty \u200eintegrating \u200enewly acquired businesses; \u200e\u200ethe ability to implement business strategies and \u200e\u200epursue business opportunities; low \u200eprofit \u200emarket segments; \u200e\u200edisruptions in or attacks (including cyber-attacks) on \u200e\u200ethe Company\u2019s information \u200etechnology, \u200einternet, network \u200e\u200eaccess or other voice or data communications systems or \u200e\u200eservices; the evolution of \u200evarious types \u200eof fraud or other \u200e\u200ecriminal behavior to which the Company is exposed; the \u200e\u200efailure of third parties to \u200ecomply with \u200etheir obligations to \u200e\u200ethe Company or its affiliates; the impact of new and \u200e\u200echanges to, or application of, \u200ecurrent \u200elaws and regulations; \u200e\u200edecline of reimbursement rates; dependence on few \u200e\u200epayors; possible new drug \u200ediscoveries; a \u200enovel business \u200emodel; \u200edependence on key suppliers; granting of permits \u200e\u200eand licenses in a highly \u200eregulated \u200ebusiness; legal proceedings and litigation, including as it relates to the civil \u200e\u200einvestigative demand \u200ereceived from the Department of Justice; \u200eincreased competition; \u200echanges in \u200eforeign currency rates; the imposition of trade restrictions such as tariffs and retaliatory counter measures; increased \u200e\u200efunding costs and market volatility due to \u200emarket illiquidity and \u200ecompetition for \u200efunding; the \u200eavailability of funds \u200e\u200eand resources to pursue operations; \u200ecritical accounting \u200eestimates and changes \u200eto accounting \u200estandards, policies, \u200e\u200eand methods used by the Company; the Company\u2019s status as an emerging growth company and a smaller reporting company; the occurrence of \u200enatural and unnatural \u200ecatastrophic \u200eevents or health epidemics or concerns; as well as those risk factors \u200ediscussed or \u200e\u200ereferred to \u200ein the Company\u2019s disclosure \u200edocuments filed with \u200ethe SEC\u200e and \u200eavailable at www.sec.gov, including the Company\u2019s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, and with \u200ethe securities \u200eregulatory authorities in certain provinces of \u200eCanada and \u200e\u200e\u200eavailable at www.sedarplus.com. Should any \u200efactor affect \u200ethe Company in an unexpected manner, or \u200eshould \u200e\u200e\u200eassumptions underlying the forward-looking \u200estatement prove \u200eincorrect, the actual results or events may \u200ediffer \u200e\u200e\u200ematerially from the results or events predicted. \u200eAny such forward-\u200elooking statements are expressly qualified \u200ein their \u200e\u200e\u200eentirety by this cautionary statement. Moreover, \u200ethe Company \u200edoes not assume responsibility for the \u200eaccuracy or \u200e\u200e\u200ecompleteness of such forward-looking \u200estatements. The \u200eforward-looking statements included in this \u200epress release are made as of the date of this press \u200erelease and the \u200eCompany undertakes no obligation to publicly \u200eupdate or revise \u200e\u200e\u200eany forward-looking statements, \u200eother than as \u200erequired by applicable law\u200e.\u200e<\/p>\n<p>For further information please visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mNTyYMfJzgdJzZBghHv45YK4uVi0uYRgklKNDwV-bodNM5WP2P-tAliDVjDaN_7t_rNq-r4EBMmunSH2ja-jUmz8uFg6fdRVpmHt3lYKFvNOm7mk34YRQduQKZI3fqbIB8Gy9_dnoZ7n-8ktqhyGuUZK3V_TSpLoeNgpeMVSaUaxZe_Y6hPQ9LIjaXUmvyEHNpYpGsF6OxPKNlbzdlW0sObxBdQgViSRdC3BnJiAH1HLPo34RJRDWnyqX0BoA5xQJ7PJY5sgF6ex0p34rJXev8KmVAcmMw6Kp8FXj5h6kLPhTRn0wlCS-rs-evW7g8PKeXZ-ntLMlKLLzn9BreJJIg9mRj02uYPj0cwuuj9s3nxw4tHw5k8yLuZZukJD6B7A3Wz_QM6cYtZrvc9rZ8gEeBoMw94BJ2D3n4NgZ-BtIqs=\" rel=\"nofollow\" target=\"_blank\">www.quipthomemedical.com<\/a>, or contact:<\/p>\n<p>Cole Stevens<br \/>VP of Corporate Development<br \/>Quipt Home Medical Corp.<br \/>859-300-6455<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JtDrx-OkV7MpIg8LdGKWoT_uJggGRi5olAkzAJNPnJB9BLgI_hpIjpppf991HtjSmz0LGFDyR9HeWPINsHWldtZo7J9pqH97iCDdf7JL6N3RqkWUQEaT0lsfpwD6zUZ4\" rel=\"nofollow\" target=\"_blank\">cole.stevens@myquipt.com<\/a><\/p>\n<p>Gregory Crawford<br \/>Chief Executive Officer<br \/>Quipt Home Medical Corp.<br \/>859-300-6455<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Vx_yvzEVrykGrgsbDhobXABfsMnPoAEGncIAH8Ctn9qkjZ-CMNvKdhSu85RZqXDnHkbgAAtVbswHeenoOBNrIofNXv1BU2lFkZW5ahdPupOV8hvbFEyRKpzfnlpo_6nL\" rel=\"nofollow\" target=\"_blank\">investorinfo@myquipt.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWU1NzI5MzQtZjc5NC00NjgwLTg4ZDAtYjc4MTAxZDhjMjlhLTEwOTk1NzMtMjAyNi0wMi0wNC1lbg==\/tiny\/Quipt-Home-Medical-Corp-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) &#8212; Quipt Home Medical Corp. (\u201cQuipt\u201d or the \u201cCompany\u201d) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the \u201cCircular\u201d) in connection with Quipt\u2019s upcoming special meeting (the \u201cMeeting\u201d) of the holders (the \u201cShareholders\u201d) of Quipt\u2019s common shares (the \u201cShares\u201d) to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt\u2019s profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d) on the EDGAR website at www.sec.gov, and on Quipt\u2019s website at https:\/\/quipthomemedical.com\/sec-filings\/. Mailing to Shareholders of the Circular and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-934353","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) &#8212; Quipt Home Medical Corp. (\u201cQuipt\u201d or the \u201cCompany\u201d) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the \u201cCircular\u201d) in connection with Quipt\u2019s upcoming special meeting (the \u201cMeeting\u201d) of the holders (the \u201cShareholders\u201d) of Quipt\u2019s common shares (the \u201cShares\u201d) to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt\u2019s profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d) on the EDGAR website at www.sec.gov, and on Quipt\u2019s website at https:\/\/quipthomemedical.com\/sec-filings\/. Mailing to Shareholders of the Circular and &hellip; Continue reading &quot;Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-04T22:20:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement\",\"datePublished\":\"2026-02-04T22:20:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/\"},\"wordCount\":2342,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/\",\"name\":\"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=\",\"datePublished\":\"2026-02-04T22:20:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/","og_locale":"en_US","og_type":"article","og_title":"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement - Market Newsdesk","og_description":"CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) &#8212; Quipt Home Medical Corp. (\u201cQuipt\u201d or the \u201cCompany\u201d) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the \u201cCircular\u201d) in connection with Quipt\u2019s upcoming special meeting (the \u201cMeeting\u201d) of the holders (the \u201cShareholders\u201d) of Quipt\u2019s common shares (the \u201cShares\u201d) to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt\u2019s profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d) on the EDGAR website at www.sec.gov, and on Quipt\u2019s website at https:\/\/quipthomemedical.com\/sec-filings\/. Mailing to Shareholders of the Circular and &hellip; Continue reading \"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-04T22:20:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement","datePublished":"2026-02-04T22:20:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/"},"wordCount":2342,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/","name":"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=","datePublished":"2026-02-04T22:20:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY0ODk2OCM3NDA5NzE5IzIwODgwMDI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quipt-home-medical-corp-announces-filing-and-mailing-of-proxy-statement-and-information-circular-and-receipt-of-interim-order-in-connection-with-plan-of-arrangement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934353","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=934353"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/934353\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=934353"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=934353"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=934353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}